Founders, investors, and support organizations active in MedTech.
Warsaw-based medtech startup developing AptaSense, a bedside analyzer for near real-time therapeutic drug monitoring. The platform uses disposable strips to measure antibiotic and protein levels in around one minute to support precise dosing in sepsis and critical care.
Dawn Health develops regulated software-as-a-medical-device products with pharmaceutical and life-science partners. The company builds digital therapeutics and companion applications for adherence, remote monitoring, and real-world clinical data capture in regulated settings.
Distalmotion develops Dexter, a hybrid robotic surgery platform intended to make robotic-assisted minimally invasive procedures more accessible to a broader hospital base. The system allows surgeons to move between robotic and laparoscopic workflows during operations to improve flexibility and operating-room integration.
Organizer of DMEA, Europe's leading digital health and healthcare IT trade fair in Berlin.
Europe's largest digital health trade fair at Messe Berlin, spanning healthcare IT, procurement, interoperability, and compliant medical software rollout. Includes the 'DMEA fuer Health Startups' program, the DMEA nova Award startup finals, and DMEA Sparks pitch visibility for early-stage health-tech companies.
Specialist cardiology congress focused on heart rhythm innovation. Price: about EUR 600-1000. Strong for ECG AI and cardiac device startups.
Opened 2007. Provides office space, mentorship, and links to Limerick's industry network for medtech, biotech, and digital media startups; supported 50+ firms. Notable alumni include Stokes Bio. Scope: Regional (Mid-West Ireland).
Deep-tech venture builder at High Tech Campus Eindhoven (est. 2015). Runs a 9-month venture-building program turning advanced tech from CERN, ESA, and others into startups; exits include Accerion. Support: co-founding teams, seed funding, R&D ecosystem access. Scope: International.
Organizer of HLTH Europe, a major conference connecting digital health innovators with healthcare decision-makers.
Pan-European health innovation conference at RAI Amsterdam connecting providers, payers, pharma, policymakers, and digital health startups. Strong entry point for navigating fragmented national healthcare systems through centralized buyer and partner access.
Angel investor and board member at COBIN Angels, Kasia is based in Switzerland and helps connect Swiss and Polish startup ecosystems. She is vice-president of the Swiss-Polish Blockchain Association and brings specialization in health economics. Her portfolio and advisory focus include Bitfold and early-stage teams using blockchain in healthcare data management and security.
Polish-Israeli medtech startup developing VGuard, a non-invasive vagus nerve stimulation system aimed at improving cognitive outcomes in patients with Alzheimer’s disease and dementia. The company is advancing clinical validation and regulatory pathways across Europe and the US.
Major French healthcare and hospital innovation expo with a large innovation village for digital health ventures. High-value event for founders targeting public-hospital procurement and clinical pilot partnerships.
MedTech robotics startup behind FIDI, an assistive feeding robot for people with upper-limb disabilities. The system combines 3D vision, AI, and adaptive utensils to align with user posture and pace.
Venture Catalysts is an innovative venture studio and venture builder program based in Porto, Portugal, specializing in spinning up companies from scientific research and technical projects. Founded around 2015 (with roots as a university initiative), Venture Catalysts takes a hands-on approach to pair scientists and engineers with business co-founders to create startups in fields like medtech, cleantech, and AI. The program identifies promising technologies (often from local universities like University of Porto or from labs across Portugal) and provides a structured process to form a company, develop an MVP, and obtain early funding. Each year, it selects a batch of projects and offers resources such as lab access, initial capital (seed grants or investment from partnered funds), and a network of corporate partners for pilots. A distinctive feature is how it integrates venture building with funding: Venture Catalysts can provide seed capital through grants or its partnered VC funds (often up to €200k), and also connects teams with larger investors for follow-ons. The studio’s track record includes helping create SWORD Health (digital physiotherapy startup that became a unicorn) and AddVolt (electric truck battery solution acquired by Daimler). These successes highlight the model’s efficacy – both companies started as technical projects in Portugal and through Venture Catalysts’ support, gained product-market fit and international traction. The venture studio is backed by both private and public stakeholders (it has worked with Portugal’s innovation agency and corporates like EDP in energy tech). Located in Porto’s up-and-coming innovation district, Venture Catalysts has contributed to making Porto a deep-tech startup hub beyond the usual Lisbon scene. The program puts heavy emphasis on team formation – often recruiting experienced entrepreneurs or MBAs to join scientific founders as CEOs or business leads, ensuring startups have both technical depth and commercial acumen. With a regional focus, it has kept many high-tech startups in Northern Portugal, strengthening the local ecosystem. In summary, Venture Catalysts serves as a venture co-founder for scientists – turning lab breakthroughs into viable companies by providing the missing pieces (business talent, early capital, industry links). Its portfolio’s achievements, like SWORD Health’s growth, demonstrate the powerful potential of the venture studio model in catalyzing innovation.
YES!Delft is a renowned tech incubator in the Netherlands, focused on turning university research and technical inventions into successful startups. Founded in 2005 by Delft University of Technology (TU Delft) – one of Europe’s top engineering schools – YES!Delft has grown into a deep-tech startup ecosystem supporting hardware and high-tech software ventures. The incubator offers a 3-4 month validation program for idea-stage teams, longer-term incubation for growth-stage startups, access to specialized labs and maker spaces, and connections to TU Delft’s extensive research facilities. Over the past 20 years, YES!Delft has incubated nearly 500 startups, collectively valued at over €1.2B. Notable alumni include Ampelmann (offshore access systems, now a global marine company) and E-nevia (electric mobility). The sectors span AI, robotics, medtech, aerospace, clean energy, and more – reflecting Delft’s engineering strengths. The incubator actively leverages partnerships: it works with corporates like KLM (aviation) and NS (railways) for pilot opportunities, and with government initiatives for grants. Startups at YES!Delft benefit from an entrepreneur-centric approach; the incubator was twice ranked a global top 5 university incubator by UBI Index. It offers an in-house venture fund (UNIIQ) that provides proof-of-concept funding (~€100k) to the most promising teams, bridging the gap to seed rounds. YES!Delft’s campus in Delft has co-working, an auditorium for events, and proximity to cutting-edge labs (e.g., quantum computing labs at QuTech). It has expanded with satellite branches in Rotterdam (focused on port and logistics tech) and The Hague (focused on AI and security) to tap regional industries. The name YES stands for “Young Entrepreneurs Society,” underscoring its community vibe: seasoned mentors, many of whom are TU Delft alumni entrepreneurs, guide newcomers. With continued support from TU Delft and the city, YES!Delft is a cornerstone of the Dutch innovation ecosystem – ensuring that inventions from classrooms and labs (like next-gen drones, solar cars, or medical devices) find their way to market via robust startups.
Impact investor and founder of the Humanites Institute, Zofia is a leading advocate of human-centric technology and responsible innovation. A former C-level executive in large financial organizations (including PZU and Link4), she supports startups and boards at the intersection of business performance and social impact. Her focus areas include fintech, medtech, and social impact, complemented by board service at major public companies and active mentorship.